Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3)
| קרן | National Institute on Drug Abuse/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 28/02/2024 |
| פקולטה | Life Sciences, Medicine, Social Sciences |
| תיאור | The purpose of this grant is to support the development of classic psychedelics (e.g., psilocybin, LSD), empathogens (e.g., MDMA), dissociatives (e.g., ketamine and related compounds), and other hallucinogens (e.g., ibogaine and its analogues) (henceforth “psychedelics”) as new treatment options for Substance Use Disorder (SUD).
Funding: $2,000,000 per year Duration: 5 years
Research Authority due date: 18.1.24 LOI (encouraged) due date: 28.1.24 Full application due date: 28.2.24 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 05/11/2023 |
